Westlake Chemical Partners LP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.2B | $1.1B | $1.2B | $1.6B | $1.2B |
| Cost of revenue | $818.8M | $717.0M | $803.3M | $1.2B | $773.2M |
| Gross profit | $347.8M | $418.9M | $387.5M | $377.4M | $441.7M |
| Selling, general & administrative | $28.3M | $28.5M | $29.8M | $29.7M | $31.0M |
| Operating income | $319.6M | $390.4M | $357.7M | $347.7M | $410.7M |
| Interest expense | $22.9M | $25.7M | $26.5M | $13.4M | — |
| Pretax income | $299.1M | $370.0M | $335.4M | $335.8M | $401.9M |
| Income tax expense | $547,000 | $835,000 | $813,000 | $1.0M | $549,000 |
| Net income | $48.7M | $62.4M | $54.3M | $64.2M | $82.5M |
| Balance Sheet | |||||
| Cash and equivalents | $44.3M | $58.3M | $58.6M | $64.8M | $17.1M |
| Current assets | $143.5M | $240.9M | $226.2M | $245.8M | $281.2M |
| Total assets | $1.3B | $1.3B | $1.3B | $1.4B | $1.5B |
| Current liabilities | $51.3M | $55.4M | $56.3M | $66.9M | $106.8M |
| Total liabilities | $454.2M | $458.6M | $460.6M | $468.3M | $508.0M |
| Cash Flow Statement | |||||
| Cash from operations | $280.5M | $485.0M | $452.0M | $463.7M | $408.4M |
| Depreciation and amortization | $128.0M | $111.9M | $110.2M | $121.1M | $108.8M |
| Capital expenditure | $78.8M | $49.0M | $46.8M | $54.1M | $81.2M |
| Free cash flow | $201.7M | $436.0M | $405.2M | $409.6M | $327.3M |
Shares outstanding 35.2M · Free float 54.8%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.